Phase III Study of adjuvant chemotherapy for the patients resected pathological stage I(T1>2cm) Non Small Cell Lung Cancer (JCOG0707).

Trial Profile

Phase III Study of adjuvant chemotherapy for the patients resected pathological stage I(T1>2cm) Non Small Cell Lung Cancer (JCOG0707).

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Jun 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Tegafur/uracil (Primary)
  • Indications Non-small cell lung cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 06 Mar 2014 Planned End Date changed from 1 Nov 2016 to 10 Nov 2018 as reported by University Hospital Medical Information Network - Japan record.
    • 17 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported in University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top